Latest News
  • ³Ô¹ÏºÚÁÏÍø and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting Read more
  • ³Ô¹ÏºÚÁÏÍø metra® System Approved for Liver Transplantation in Canada Read more
  • ³Ô¹ÏºÚÁÏÍø CTO and co-founder Prof. Constantin Coussios elected Fellow of the UK’s Academy of Medical Sciences Read more
  • ³Ô¹ÏºÚÁÏÍø Opens State-of-the-Art Research, Development, and Production Headquarters in Oxford, UK Read more
  • Appointment of Stephen M. Deitsch as new Chief Financial Officer Read more
  • Successful Use of a Genetically Engineered Porcine Liver with a Human Donor Read more
  • ³Ô¹ÏºÚÁÏÍø Honours the Life of Sir Roy Calne – Pioneer in Transplant Medicine Read more
  • ³Ô¹ÏºÚÁÏÍø completes £25m fundraise Read more
  • ³Ô¹ÏºÚÁÏÍø Chief Medical Officer, Professor Peter Friend, Elected as Vice President of Royal College of Surgeons of England Read more
  • ³Ô¹ÏºÚÁÏÍø Enrols First US Patient for Post-Approval Study Read more
Latest Events

Press and media enquiries

Should you have any enquiries about ³Ô¹ÏºÚÁÏÍø or the metra® device please contact ³Ô¹ÏºÚÁÏÍø Commercial Director, Andy Self.

T: +44 (0) 1865 784156
E: marketing@organox.com


References:

UK/US MD-040-14-1 - September 2022